Compare EVO & CLOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVO | CLOV |
|---|---|---|
| Founded | 1993 | 2014 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.3B |
| IPO Year | 2021 | N/A |
| Metric | EVO | CLOV |
|---|---|---|
| Price | $2.99 | $2.72 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $7.00 | $4.23 |
| AVG Volume (30 Days) | 105.3K | ★ 4.4M |
| Earning Date | 11-05-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $887,396,457.00 | ★ $1,773,564,000.00 |
| Revenue This Year | N/A | $41.68 |
| Revenue Next Year | $8.80 | $37.69 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 32.15 |
| 52 Week Low | $2.84 | $2.12 |
| 52 Week High | $5.10 | $4.87 |
| Indicator | EVO | CLOV |
|---|---|---|
| Relative Strength Index (RSI) | 40.74 | 53.81 |
| Support Level | $2.86 | $2.41 |
| Resistance Level | $3.24 | $2.80 |
| Average True Range (ATR) | 0.10 | 0.10 |
| MACD | 0.01 | 0.05 |
| Stochastic Oscillator | 28.57 | 83.50 |
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.